ES

Ebrahim Sirajuddin Ayesha Zuleka Hameeda

Director Director DIN 09219737
DIN 09219737 First appointment Jun 2021 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ebrahim Sirajuddin Ayesha Zuleka Hameeda

Data last updated:

Ebrahim Sirajuddin Ayesha Zuleka Hameeda was a Director at Creatus Lifesciences Private Limited (2021–2022). The company operates in Chemicals and Materials.

DIN 09219737
Primary Designation Director
Industry Chemicals and Materials
First Appointment 29 Jun 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Creatus Lifesciences Private Limited U73100TZ2021PTC036460
Director29 Jun 20212021₹26.4 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Creatus Lifesciences Private Limited
Premium access

Shareholding and investment profile for Ebrahim Sirajuddin Ayesha Zuleka Hameeda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ebrahim Sirajuddin Ayesha Zuleka Hameeda

Ebrahim Sirajuddin Ayesha Zuleka Hameeda was first appointed on 29 Jun 2021 as Director at Creatus Lifesciences Private Limited.

Ebrahim Sirajuddin Ayesha Zuleka Hameeda held 1 earlier board appointment: Creatus Lifesciences Private Limited (Director, 29 Jun 2021 to 26 Nov 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available